期刊
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
卷 138, 期 -, 页码 173-177出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.critrevonc.2019.04.006
关键词
Propranolol; Breast cancer; Beta adrenergic receptors; Beta blocker
Pre-clinical data has shown that beta adrenergic stimulation can affect the development and progression of many types of cancer. The use of beta blockers as an anti-neoplastic therapy has been studied in retrospective trials and observational trials, but no definitive conclusions about efficacy have been made. Within the realm of breast cancer, significant advances in therapy have led to improved survival outcomes, yet there is room for improvement. Beta adrenergic blockade may prove an effective adjunct to standard breast cancer therapy, with little associated toxicity. This article provides a review of the published literature on beta blockade as an adjunctive cancer therapy, with a focus on breast cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据